{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:42Z","timestamp":1792834722968,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Piperacillin\u2013tazobactam is a widely used antibiotic, but its adverse effects, particularly drug fever and hematological toxicities, are often underestimated. The concurrent occurrence of drug fever and agranulocytosis may complicate the differential diagnosis of persistent or recurrent fever, particularly in patients with stroke-associated pneumonia. We report a case of probable piperacillin\u2013tazobactam\u2013associated drug fever and agranulocytosis and review the relevant literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>\n                      A 45-year-old woman with cerebral infarction complicated by stroke-associated pneumonia received prolonged piperacillin\u2013tazobactam therapy. During continued treatment, she developed recurrent high fever accompanied by a progressive decline in neutrophil count, with an absolute neutrophil count nadir of 0.3\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>After systematic evaluation of infectious and noninfectious causes, the patient was considered to have probable piperacillin\u2013tazobactam\u2013associated drug fever and agranulocytosis. A Naranjo Adverse Drug Reaction Probability Scale score of 7 supported a probable association between piperacillin\u2013tazobactam exposure and the observed adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Piperacillin\u2013tazobactam was discontinued. Granulocyte-supportive treatment, including granulocyte colony-stimulating factor, was administered, and the antimicrobial regimen was adjusted to address the possibility of concurrent or secondary infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Following discontinuation of piperacillin\u2013tazobactam, granulocyte-supportive treatment, and antimicrobial adjustment, the patient\u2019s fever resolved and the neutrophil count gradually recovered. She was discharged in stable clinical condition, and no recurrence of fever was reported during follow-up for up to 1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>In patients receiving prolonged piperacillin\u2013tazobactam therapy, recurrent or persistent fever accompanied by a declining neutrophil count should raise suspicion for drug fever and hematological toxicity. Serial blood-cell monitoring and careful evaluation of the temporal relationship between drug exposure and clinical manifestations are important for early recognition. However, infectious and other noninfectious etiologies should be systematically evaluated before attributing these findings to piperacillin\u2013tazobactam, and causality should be interpreted cautiously when multiple therapeutic interventions are performed concurrently.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050398","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:56Z","timestamp":1787968856000},"page":"e50398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Poststroke fever etiology"],"prefix":"10.1097","volume":"105","author":[{"given":"Lijiang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2068-9787","authenticated-orcid":false,"given":"Menglu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s11096-020-01071-8","article-title":"Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.","volume":"42","author":"Wang","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.2147\/DDDT.S544195","article-title":"Applying the lasso model to identify risk factors for piperacillin-tazobactam-induced leukopenia.","volume":"19","author":"Liu","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"950859","DOI":"10.3389\/fpubh.2022.950859","article-title":"Bibliometric analysis of global research trends on post-stroke pneumonia: current development status and research Frontiers.","volume":"10","author":"Li","year":"2022","journal-title":"Front Public Health"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.2147\/IDR.S439241","article-title":"Risk factors, outcomes, and predictions of extensively drug-resistant acinetobacter baumannii nosocomial infections in patients with nervous system diseases.","volume":"16","author":"Huang","year":"2023","journal-title":"Infect Drug Resist"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"e947444","DOI":"10.12659\/MSM.947444","article-title":"Predictive value of early nursing scores on 90-day outcomes in intracerebral hemorrhage patients.","volume":"31","author":"Feng","year":"2025","journal-title":"Med Sci Monit"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12883-024-03755-4","article-title":"Bacterial stroke-associated pneumonia: microbiological analysis and mortality outcome.","volume":"24","author":"Aboulfotooh","year":"2024","journal-title":"BMC Neurol"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/2396987319851335","article-title":"Antibiotic treatment for pneumonia complicating stroke: recommendations from the pneumonia in stroke consensus (PISCES) group.","volume":"4","author":"Kishore","year":"2019","journal-title":"Eur Stroke J"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"1219604","DOI":"10.3389\/fneur.2023.1219604","article-title":"Serum amyloid A is a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.","volume":"14","author":"Chang","year":"2023","journal-title":"Front Neurol"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.12669\/pjms.37.4.3932","article-title":"The value of serum procalcitonin in the anti-infection therapy of acute stroke patients.","volume":"37","author":"Wang","year":"2021","journal-title":"Pak J Med Sci"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/CAD.0000000000001541","article-title":"Venetoclax dose adjustment due to drug-drug interactions: a case report and literature review.","volume":"35","author":"Fan","year":"2024","journal-title":"Anticancer Drugs"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1038\/s41598-021-86570-y","article-title":"Detection of extended spectrum beta-lactamase genes in Pseudomonas aeruginosa isolated from patients in rural Eastern Cape Province, South Africa.","volume":"11","author":"Hosu","year":"2021","journal-title":"Sci Rep"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1136\/ejhpharm-2020-002575","article-title":"An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage.","volume":"29","author":"Lv","year":"2022","journal-title":"Eur J Hosp Pharm"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"e232944","DOI":"10.1136\/bcr-2019-232944","article-title":"Piperacillin-tazobactam induced bicytopenia in low cumulative treatment doses.","volume":"12","author":"Chen","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ejhpharm-2017-001243","article-title":"A case of probable piperacillin\/tazobactam-induced bone marrow suppression in a pregnant woman.","volume":"26","author":"ElSalem","year":"2019","journal-title":"Eur J Hosp Pharm"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2152\/jmi.68.368","article-title":"A puerperal patient with agranulocytosis during tazobactam\u2009\/\u2009piperacillin administration\u2005:\u2005A case report.","volume":"68","author":"Iwazawa","year":"2021","journal-title":"J Med Invest"},{"key":"R17-20261024","first-page":"005460","article-title":"Piperacillin\/tazobactam induced immune-mediated anaemia and thrombocytopenia.","volume":"12","author":"Fritz","year":"2025","journal-title":"Eur J Case Rep Intern Med"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12098-022-04420-9","article-title":"Infections in critically ill children.","volume":"90","author":"Kannan","year":"2023","journal-title":"Indian J Pediatr"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"bcr2016215814","DOI":"10.1136\/bcr-2016-215814","article-title":"Drug fever induced by piperacillin\/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.","volume":"2016","author":"Swe","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"2050313X241285675","DOI":"10.1177\/2050313X241285675","article-title":"Fever and reversible laboratory abnormalities associated with prolonged use of piperacillin\/tazobactam: a case report.","volume":"12","author":"Shen","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"key":"R21-20261024","first-page":"290","article-title":"Hematologic adverse effects of prolonged piperacillin-tazobactam use in adults.","volume":"35","author":"Benli","year":"2018","journal-title":"Turk J Haematol"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/INF.0000000000001351","article-title":"Piperacillin-tazobactam-induced adverse drug events in pediatric patients on outpatient parenteral antimicrobial therapy.","volume":"36","author":"Yusef","year":"2017","journal-title":"Pediatr Infect Dis J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:01:03Z","timestamp":1792832463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050398"}},"subtitle":["A case report and review of the literature on probable piperacillin\u2013tazobactam-induced drug fever and agranulocytosis"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":21,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050398","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}